In this paper, we report a synthesis of magnetic porous hollow silica nanotubes ͑MPHSNTs͒ using sol-gel method. The MPHSNTs were fabricated by coating Fe 3 O 4 nanoparticles and silica on surfactant hexadecyltrimethylammonium bromide ͑CTAB͒ modified CaCO 3 nanoneedles surface under alkaline condition. CaCO 3 nanoneedles and surfactant CTAB are introduced as nanotemplates to form the hollow and porous structures, respectively. After removing CTAB by calcination and etching CaCO 3 nanoneedles away in diluted acetic acid, magnetic porous hollow silica nanotubes with Fe 3 O 4 nanoparticles embedded in the silica shell were achieved. The products were characterized by scanning electron microscopy, transmission electron microscopy, and N 2 adsorption-desorption isotherms. Superconducting quantum interference device measurement shows that the nanotubes exhibit superparamagnetism property at room temperature and ferromagnetism below the blocking temperature. Toxicity test was also performed for the magnetic nanocarriers, showing good bio-compatibility. Magnetic porous hollow silica nanotubes with advantages of high surface area, good bio-compatibility, and superparamagnetism are one of the novel drug nanocarriers for nanomedicine applications. © 2009 American Institute of Physics. ͓DOI: 10.1063/1.3072048͔
In the past few years, our group has performed a series of synthesis for magnetic hollow silica nanospheres for biomedicine applications. nanoparticles were encapsulated in the hollow cores of the silica nanospheres, providing superparamagnetic characteristic at room temperature. A slow release of ibuprofen was observed due to the porous structure. 1 On the other hand, silica nanotube is also another novel nanostructure that can be potentially used as carrying more drugs, compared with silica nanospheres. Different from the nanospheres exposed only outside surface, nanotubes with open ends offer both inside and outside surface to interact with drug molecules, which largely increase surface/volume ratio and improve drug loading capacity. In this paper, we present a synthesis of magnetic porous hollow silica nanotubes using double template method. Magnetite nanoparticles were first attached on the pure CaCO 3 nanoneedle surface ͑first template͒ fabricated through rotating packed bed ͑RPB͒ method, and then followed by self-assembly of cationic surfactant hexadecyltrimethylammonium bromide ͑CTAB͒ as the second template to direct the porous formation while silica shell was being formed. After removing both the templates, porous silica nanotubes with magnetite nanoparticles embedded in the shell were achieved. The synthesis procedure using so-gel method is similar to the one of magnetic porous silica nanospheres.
1 CaCO 3 nanoneedles were first fabricated by a RPB method. 14 In fact, the size of the as-prepared CaCO 3 nanoneedles was inhomogeneous and hard to be directly used in the synthesis. Therefore, a size selection process was performed to achieve more homogenous nanoneedles for the later on synthesis. 20 g of original CaCO 3 nanoneedles was ultrasonically dispersed in 200 ml ethanol for 2 h then introduced to a series of centrifuging with different rates and times. Then the size of purified samples was checked with scanning electron microscope ͑SEM͒. 3 g size selected CaCO 3 nanoneedles with the dimension of less than 1000 nm in length and 200 nm in diameter were ultrasonically dispersed in a mixture of 80 ml ethanol ͑A Aper Alcohol and Chemical Co.͒ and 20 ml distilled water in a three-neck flask for 25 min. Then 0. trasonic for another 10 min. Superparamagnetic Fe 3 O 4 nanoparticles were prepared by a method based on the hydrolysis of chelate metal alkoxide complexes at elevated temperature in solutions of diethylene glycol, which was published elsewhere. 15 After that, 1 g of CTAB ͑99+ %; Johnson Matthew Co.͒ was applied to the mixture and ultrasonic dispersed for 20 min. [16] [17] [18] Then the flask was settled under a mechanical stirrer and stirred at a rate of 500 rpm. Appropriate amount of ammonia ͑30%; J.T. Baker͒ and 3.2 ml of TEOS ͑99.9%; Johnson Matthew͒ was added into the reaction mixture within 10 min to reach the pH value 11. The system was continuously stirred at 500 rpm for 2 h at room temperature, and then aged at room temperature for 4 h. After centrifuging washing and drying, the products were introduced to calcination for first 3 h at 300°C, then 5 h at 550°C to remove the surfactant template. After calcination, the product was immersed in diluted acetic acid ͑J. T. Baker͒ solution ͑HAc: H 2 O=1:15͒ for 4.5 h to remove the CaCO 3 template. The product was then dried at 70°C, following two times washes with distilled water and one time with ethanol. Finally, the magnetic porous hollow silica nanotubes with magnetite nanoparticles embedded in the shell was obtained. Meanwhile, we also fabricated magnetic silica nanotubes without pores as a comparison.
A Carl Zeiss 1530 VP field emission scanning electron microscope ͑FESEM͒ and JEOL 2010 transmission electron microscope ͑TEM͒ was used to examine the morphologies of the nanotubes. EDAX ͑AMETEK, Inc.͒ energy dispersive spectroscopy ͑EDS͒ was applied to determine the composition of the products. A micromeritics ASAP 2010 analyzer was employed to measure N 2 adsorption-desorption isotherms at 77 K to get the Barrett-Joyner-Halenda ͑BJH͒ pore size distributions. The magnetic properties were measured on a Quantum Design MPMS-5S superconducting quantum interference device ͑SQUID͒ magnetometer. Figure 1 is a SEM image providing morphology information of the magnetic porous hollow silica nanotubes ͑MPHSNT͒. The diameter of the nanotubes is below 200 nm and the length is within 1000 nm. Most of the nanotubes were broken in the middle, leaving the opened ends and exposed inner hollow space for drug loading. Figure 2͑a͒ is a TEM image showing the middle region of a single MPHSNT. The thickness of silica shell is about 20 nm and the magnetite nanoparticles with diameter about 10 nm appear as darker dots. It can be clearly seen that from the edge of the shells the magnetite nanoparticles ͑denoted by arrows͒ are successfully embedded in the silica shell. Figure 2͑b͒ is the EDS analysis showing the Si, Fe, and O besides the C and Cu peaks from the sample grid. Also, the absence of Ca peak indicates that the CaCO 3 template was completely etched away by the diluted acetic acid, leaving the hollow structure.
The cationic surfactant CTAB was used as second template to direct porous structure formation in the silica shell. The pore size can be evaluated by N 2 adsorption-desorption isotherms and calculated by BJH method. Compared with the samples without surfactant modification, CTAB modified nanotubes represent a quite uniform pore size distribution around 2.1 nm. These pores behave as nanochannels run through the silica shell, providing porous structure for both inside and outside surface for drug delivery.
The magnetic properties of the MPHSNTs were measured by SQUID. Zero-field-cooled ͑ZFC͒ and field-cooled ͑FC͒ magnetization data were measured in the temperature range of 5-300 K, as shown in Fig. 3͑a͒ . In the ZFC measurement, the initial field was set to zero when cooling the sample from 300 to 5 K. A field of 100 Oe was applied and the magnetization was measured as the sample was heated from 5 to 300 K. In FC measurement, a field of 100 Oe was applied as the sample was cooled from 300 to 5 K and the magnetization was measured as the sample was heated from 5 to 300 K in the field of 100 Oe. The ZFC curve shows a maximum at 83.7 K, which is the blocking temperature ͑T B ͒ of the magnetic nanoparticles in the MPHSNTs. Such a behavior is the characteristic of superparamagnetism and is due to the progressive blocking of the magnetic moment of the nanoparticles when decreasing the temperature. The MPHSNTs exhibit superparamagnetism and ferromagnetism above and below the blocking temperature, respectively. To ensure these features, the field-dependent hysteresis loops of the MPHSNTs were measured at temperatures both above and below the blocking temperature as shown in Fig. 3͑b͒ . The hysteresis loop at 5 K shows a saturation magnetization of 1.35 emu/g ͑at the field of 10 000 Oe͒ and a coercivity of 152 Oe, which confirms that the MPHSNTs are ferromagnetic below the blocking temperature. The absence of coercivity in the hysteresis loop at 300 K indicates a superparamagnetic behavior. The MPHSNTs have superparamagnetic properties, which means they can be attracted by a magnetic field but retain no residual magnetism when the magnetic field is removed at room temperature.
The drug loading and releasing study for MPHSNTs is still under processing. However, according to our previously published result, the drug-loading efficiency for 75 mg magnetic porous hollow silica nanospheres synthesized using the similar method with porous nanotubes was 14.21% from 1.8 mg/ml ibuprofen/hexane solution.
1 Since nanotubes exposed both the inside and outside surface which results in an increased surface/volume ratio, comparing with nanospheres, we have reason to estimate that the drug loading efficiency for MPHSNTs will be the same as, or even better, than the one of nanospheres.
Toxicity test was also performed to assess the biocompatibility of MPHSNT. Rat brain cells were exposed to MPHSNT and copper nanoparticles in a concentration of 50 g / ml, respectively. The cells were incubated with the nanosamples for 4.5 h under normal growth conditions in a 5% CO 2 incubator, and then differently stained to show both the dead and live cells under microscope. Compared with blank control group which was incubated without any nanosamples, the cells treated with copper nanoparticles are injured and died; but cells exposed to MPHSNT appear similar to control cells, in both amount and morphology aspects.
This means the MPHSNT has quite low toxicity effect to the brain cell showing bio-compatibility.
In summary, the magnetic porous hollow silica nanotubes were fabricated using double-template method. The nanotubes with diameter less than 200 nm and pore size about 2.1 nm were formed after the calcination and weak acid etching. The magnetite nanoparticles were embedded in the silica shell and provide superparamagnetism for the MPHSNTs at room temperature. The pores as nanochannels connect inside and outside shell surface together for drug carrying and delivering. Also, toxicity test demonstrates that the MPHSNTs are biocompatible and potentially useful for targeted delivery and controlled release. 
